Generics BulletinFour biosimilars sponsors – Biocon Biologics, Gedeon Richter, Mabxience and Zentiva – have each received dual positive opinions from the European Medicines Agency’s Committee for Medicinal Products fo
Generics BulletinCould Biocon Biologics’ US settlement over Eylea (aflibercept) be the first of many? The Indian biosimilars giant has just announced that it has settled US patent litigation with Regeneron over the op
Generics BulletinThe day has finally come. Biocon Biologics has received approval for its bevacizumab biosimilar from the US Food and Drug Administration, after being delayed for several years due to facility inspecti
ScripEli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec